As the American population gets older, the demand for medical services has increased and is expected to continue to increase for the foreseeable future. One such company that provides support programs, and disease management is strategically positioned to capture a large portion of this growing population. That company, Healthways Inc. , is the Zacks Bull of the Day.
This Zacks Rank #1 (Strong Buy) company is the leading and largest provider of specialized, comprehensive Health and Care Support programs and services, including disease management and care enhancement services, to health plans, hospitals and government, in addition to outcomes-driven wellness programs to health plans and employers, in states, the District of Columbia, Puerto Rico and Guam. Healthways helps people lead healthier lives while reducing overall healthcare costs. As The Health/Care Trust Channel, Healthways provides people the support they need when they need it to enable them to make better choices and live healthier lives.
Recent Earnings Results
Healthways reported Q2 16 results last week, and they destroyed the Zacks Consensus Earnings estimate, and posted a +5300% positive earnings surprise. Specifically, the company posted year over year gains in revenue growth from operations +10.2%, net income from continuing operations +85.2%, and operating income +10.3%.
Management’s Take
According to CEO Donato Tramuto, “We completed the sale of our Total Population Health Services (TPHS) business to Sharecare as expected on July 31st. Our second-quarter operating results provide a much clearer picture of the strength of the Company’s Network Solutions business. Additionally, we have good visibility to consistent quarterly performance for the rest of this year and, as previously stated, we expect the Company’s financial profile by the end of 2016 to include annualized revenue greater than $500 million with EBITDA margins in excess of 20%.”
Price and Earnings Consensus Graph
As you can see in the graph below, the company’s stock price and future earnings estimates have leaped upwards after their earnings report last week.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
As the American population gets older, the demand for medical services has increased and is expected to continue to increase for the foreseeable future. One such company that provides support programs, and disease management is strategically positioned to capture a large portion of this growing population. That company, Healthways Inc. , is the Zacks Bull of the Day.
This Zacks Rank #1 (Strong Buy) company is the leading and largest provider of specialized, comprehensive Health and Care Support programs and services, including disease management and care enhancement services, to health plans, hospitals and government, in addition to outcomes-driven wellness programs to health plans and employers, in states, the District of Columbia, Puerto Rico and Guam. Healthways helps people lead healthier lives while reducing overall healthcare costs. As The Health/Care Trust Channel, Healthways provides people the support they need when they need it to enable them to make better choices and live healthier lives.
Recent Earnings Results
Healthways reported Q2 16 results last week, and they destroyed the Zacks Consensus Earnings estimate, and posted a +5300% positive earnings surprise. Specifically, the company posted year over year gains in revenue growth from operations +10.2%, net income from continuing operations +85.2%, and operating income +10.3%.
Management’s Take
According to CEO Donato Tramuto, “We completed the sale of our Total Population Health Services (TPHS) business to Sharecare as expected on July 31st. Our second-quarter operating results provide a much clearer picture of the strength of the Company’s Network Solutions business. Additionally, we have good visibility to consistent quarterly performance for the rest of this year and, as previously stated, we expect the Company’s financial profile by the end of 2016 to include annualized revenue greater than $500 million with EBITDA margins in excess of 20%.”
Price and Earnings Consensus Graph
As you can see in the graph below, the company’s stock price and future earnings estimates have leaped upwards after their earnings report last week.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>